OKYO Pharma's Chairman Acquires Shares, Bringing Total Holding to 10.5 Million

OKYO Pharma's Chairman and Founder, Gabriele Cerrone, has acquired 24,551 shares of the company's ordinary shares, bringing his total holding to 10,516,297 shares. Urcosimod, a lipid conjugated chemerin peptide agonist, is a treatment for neuropathic corneal pain and dry eye disease. OKYO is focused on developing innovative therapies for these conditions.